申请人:MILLENNIUM PHARMACEUTICALLS, INC.
公开号:US20160333007A1
公开(公告)日:2016-11-17
The present invention provides a compound of formula I:
wherein R
1
, X
1
, X
2
, R
2
, R
3
, R
4
, R
5
, n, and m are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
本发明提供了一种具有如下式I的化合物:其中R1、X1、X2、R2、R3、R4、R5、n和m如规范中所描述。这些化合物是VPS34的抑制剂,因此可用于治疗增殖性、炎症性或心血管疾病。